Axalta Coating Systems (AXTA) downside risk is nearly priced in, underpinned by resilient performance of its core segments and strong execution from the management, UBS analysts said Monday in a research note.
Axalta Coating's stock is almost pricing in the analysts' downside scenario, which assumes sales declining about 9% below their estimate of 2025 sales growth of 1.1%. The analysts are also forecasting $930M in earnings before interest, taxes, depreciation and amortization, or EBITDA, about 18% below their 2025 EBITDA estimate of $1.14B. This leads to an average enterprise value/EBITDA multiple, of about $33 per share, which is 5% above current trading.
Looking ahead to 2025/26, the analysts assume only new wins and 2% declines in auto production versus flat previously. They also sees less downside potential in industrial and refinish volumes following a period of weakening already.
UBS upgraded Axalta Coating to buy from neutral, but decreased their price target on the stock to $40 from $42.
Price: 29.22, Change: -0.51, Percent Change: -1.72
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.